|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 36, 1390-1397, Copyright © 1995 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
M Schaumberger, B Schafer and BJ Lachenmayr
Section of Psychophysics and Physiological Optics, University Eye Hospital, Munich, Germany.
PURPOSE. This study examined how FASTPAC, a fast strategy for the Humphrey Field Analyzer (HFA), compares to the standard 4/2-dB full threshold strategy in patients with glaucoma. METHOD. The author tested one eye each of 50 patients with glaucoma (23 with only relative defects, 27 with at least one absolute defect; age range, 25 to 79 years; median age, 61.5 years) with both strategies using program 30-2 of the HFA (stimulus size III). Global visual field indices as calculated by Statpac, unweighted mean sensitivity, and examination time were compared. In addition, a point by point analysis of the sensitivity values was performed. RESULTS. Between the two strategies, no significant differences were found for indices directly related to the sensitivity values (mean sensitivity [MS], mean deviation [MD]) or for the actual thresholds. For the entire population, FASTPAC showed higher mean short-term fluctuation (SF; P = 0.018), lower mean pattern standard deviation (PSD; P = 0.006), and mean corrected PSD (CPSD; P < 0.001) values and a time reduction of more than 30% (P < 0.001) compared to the standard strategy. These differences between the strategies were found to be independent of the amount of field loss, except for PSD (P = 0.001). No age influence was present. Statistically significant linear regression (r > 0.70, P < 0.001) was found between the FASTPAC values of MS, MD, PSD, CPSD, and the corresponding values determined with the standard strategy. No correlation exists for SF (r < 0.46, P > 0.030). CONCLUSIONS. FASTPAC provides a considerable time reduction at the cost of higher threshold fluctuation. This may lead to problems in detecting relative defects or changes in differential light threshold in follow-up examinations.
This article has been cited by other articles:
![]() |
E. L. Berson, B. Rosner, M. A. Sandberg, C. Weigel-DiFranco, A. Moser, R. J. Brockhurst, K. C. Hayes, C. A. Johnson, E. J. Anderson, A. R. Gaudio, et al. Clinical Trial of Docosahexaenoic Acid in Patients With Retinitis Pigmentosa Receiving Vitamin A Treatment Arch Ophthalmol, September 1, 2004; 122(9): 1297 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Keltner, C. A. Johnson, J. M. Quigg, K. E. Cello, M. A. Kass, M. O. Gordon, and for the Ocular Hypertension Treatment Study Group Confirmation of Visual Field Abnormalities in the Ocular Hypertension Treatment Study Arch Ophthalmol, September 1, 2000; 118(9): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heijl, B. Bengtsson, and V. M. Patella Glaucoma Follow-up When Converting From Long to Short Perimetric Threshold Tests Arch Ophthalmol, April 1, 2000; 118(4): 489 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Wild, I. E. Pacey, E. C. O’Neill, and I. A. Cunliffe The SITA Perimetric Threshold Algorithms in Glaucoma Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1998 - 2009. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |